Order by 12pm AEDT, Monday to Friday, for same-day shipping!
Order by 12pm AEDT, Monday to Friday, for same-day shipping!
Selective Androgen Receptor Modulators (SARMs) have captured major scientific and clinical interest for their potential to mimic the muscle-building effects of anabolic steroids, but with greater tissue selectivity and fewer side effects. While none are FDA-approved for human use, several SARMs have undergone extensive study in clinical trials, primarily for muscle wasting, osteoporosis, and cancer-related cachexia.
This article explores the most studied SARMs, their research outcomes, and what current data tells us about their safety and effectiveness.
SARMs are compounds designed to bind selectively to androgen receptors in muscle and bone tissue.
Unlike anabolic steroids, which act on multiple organs and can cause unwanted effects such as prostate enlargement or hormone suppression, SARMs aim to stimulate muscle growth and bone density while reducing impact on other tissues.
Their selective activity makes them a promising class of investigational drugs for conditions such as:
Enobosarm, also known as Ostarine or MK-2866, is the most studied SARM to date.
Developed by GTx, Inc., it has been the subject of over 25 clinical studies involving more than 1,700 participants across multiple Phase 2 and Phase 3 trials.
While enobosarm improved body composition metrics, gains in strength and function were inconsistent. Its tissue selectivity remains promising, but FDA approval is still pending due to mixed efficacy data.
LGD-4033, or Ligandrol, is another well-researched SARM with strong anabolic effects and good receptor selectivity.
It has been tested in healthy men and older adults for its ability to increase lean body mass.
LGD-4033 demonstrated robust increases in lean mass and favorable safety in short-term studies, positioning it among the top SARMs under clinical investigation.
RAD-140 (Testolone) has gained attention for its potential neuroprotective and anabolic effects.
While data is more limited compared to enobosarm and ligandrol, preclinical and early-phase human studies show strong anabolic potency with selective activity in muscle tissue.
Early-phase human trials suggest RAD-140 may promote muscle growth and improve body composition, but more long-term data is needed to validate its safety profile.
RAD-140 remains one of the most potent experimental SARMs, showing promise for both muscle and neurological health research.
While SARMs were designed to minimize the risks of anabolic steroids, studies reveal potential side effects and safety concerns:
Both the FDA and World Anti-Doping Agency (WADA) have issued warnings about SARM use, emphasizing that they remain investigational drugs. Recreational use, particularly in bodybuilding, poses additional risks, as products marketed online may be mislabeled or contaminated.
SARMs continue to be explored for medical applications such as:
Research continues at a rapid pace, with the androgen receptor pathway remaining a central focus in anabolic and anti-catabolic drug development.
| SARM Compound | Clinical Stage | Primary Goal | Results Summary |
| Enobosarm (MK-2866) | Phase 3 | Muscle wasting, breast cancer | Increased lean mass; modest strength improvement |
| LGD-4033 | Phase 2 | Sarcopenia, frailty | Increased lean mass; short-term safety acceptable |
| RAD-140 | Early phase | Muscle loss, neuroprotection | Preclinical anabolic and neuroprotective effects |
These compounds show encouraging potential for improving lean mass, muscle strength, and bone density, but no SARM has yet achieved FDA approval for medical use.
For readers looking to understand related research topics:
If you’re interested in exploring advanced SARM research formulations, visit our SARMs for Sale collection.
Discover the power of scientifically backed SARMs, trusted by Australian fitness professionals for their performance-enhancing potential. Whether your focus is on muscle growth, recovery, or endurance, our range is rigorously tested and precision-formulated to help you train smarter and achieve visible results, safely and effectively.
SARMs are designed to reduce the side effects of traditional steroids by targeting muscle and bone tissues selectively. However, long-term safety data is still limited.
Enobosarm (MK-2866) is the most studied SARM, with over 25 clinical trials conducted on its effects on muscle mass and function.
Yes. Clinical trials have shown occasional elevations in liver enzymes and rare cases of liver injury. SARMs should not be used without medical supervision.
SARMs are legal to purchase for research purposes but not for human consumption. Always buy from reputable suppliers that clearly state their research-grade status.
